Drugs / CRV 101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03820414 | Jan 2019 → Apr 2020 | herpes zoster | Curevo Inc | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CRV-101 | “The purpose of this clinical trial is to evaluate the safety, tolerability, and immunogenicity of vaccine candidate CRV-101, investigational vaccine in healthy adult subjects...” NCT03820414 ↗ |
| Modality | Vaccine | “The purpose of this clinical trial is to evaluate the safety, tolerability, and immunogenicity of vaccine candidate CRV-101, investigational vaccine in healthy adult subjects...” NCT03820414 ↗ |
| Route | Intramuscular | “administered intramuscularly (IM) in deltoid region of non-dominant arm” NCT03820414 ↗ |